Travere Therapeutics to Present at Upcoming Investor Conferences
SAN DIEGO, May 27, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will present at the following upcoming virtual investor conferences in June:
Jefferies Virtual Healthcare Conference
Date: Wednesday, June 2, 2021
Time: 1:00 p.m. ET
JMP Securities Life Sciences Conference
Date: Wednesday, June 16, 2021
Time: 11:00 a.m. ET
BMO Biopharma Day: Spotlight on Rare Disease and Ophthalmology
Date: Tuesday, June 22, 2021
Time: 11:15 a.m. ET
Live webcasts will be available at and archived replays will be accessible for up to 30 days.
About Travere Therapeutics
At Travere Therapeutics we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com
Contact:
Chris Cline, CFA
Senior Vice President, Investor Relations & Corporate Communications
888-969-7879
